Femasys (FEMY) vs Milestone Scientific (MLSS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Milestone Scientific (MLSS) has outperformed Femasys (FEMY) over the past year, losing 23.4% versus a loss of 82.9%. Over five years, MLSS leads with a -82.9% price change compared with -98.5% for FEMY. Milestone Scientific is the larger company by market cap ($32.6 million vs $17.1 million), about 1.9 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | FEMY | MLSS |
|---|---|---|
| Share price | $2.05 | $0.36 |
| Market cap | $17.13M | $32.62M |
| 1-day change | +2.25% | -2.70% |
| YTD return | -82.25% | +33.33% |
| 1-year return | -82.87% | -23.40% |
| 5-year return | -98.54% | -82.94% |
| EPS (TTM) | $-3.28 | $-0.04 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $22.20 | $0.58 |
| 52-week low | $1.94 | $0.22 |
| Distance from 52-week high | -90.79% | -37.93% |
| Analyst consensus | none | none |
| Avg. price target upside | +600.73% | +247.22% |
| Average volume | 722.09K | 128.06K |
| Shares outstanding | 8.38M | 90.61M |
| Employees | 51 | 15 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Instruments & Supplies | Medical Instruments & Supplies |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- MLSS has outperformed FEMY by 59.5 percentage points over the past year.
About Femasys
FEMY stock →Femasys Inc., a biomedical company, develops and commercializes therapeutic and diagnostic products for women's reproductive health needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination device; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemSperm, a sperm handling kit; FemChec, a confirmation test for tubal patency; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis; and FemCath, a cornual balloon catheter for selective tube evaluation.
Healthcare · Medical Instruments & Supplies · 51 employees
About Milestone Scientific
MLSS stock →Milestone Scientific Inc., a biomedical technology company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical and dental use in the United States, China, and internationally. It operates through Dental and Medical segments.
Healthcare · Medical Instruments & Supplies · 15 employees
FEMY vs MLSS FAQ
Which is bigger, Femasys or Milestone Scientific?
Milestone Scientific (MLSS) is larger, with a market capitalization of $32.62M compared with $17.13M for Femasys (FEMY).
Which stock has performed better over the past year, FEMY or MLSS?
MLSS returned -23.40% over the past 12 months, compared with -82.87% for FEMY (price return, excluding dividends). Past performance does not predict future results.
Are Femasys and Milestone Scientific in the same industry?
Yes. Both are classified in the Medical Instruments & Supplies industry within the Healthcare sector.